이온 바이오파마AEON 주가

12 Health Care Stocks Moving In Monday's Intraday Session

AEON Biopharma Q1 EPS $(0.29) Misses $(0.13) Estimate

AEON Biopharma (AMEX:AEON) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.13) by 141.67 percent. This is a 112.72 percent decrease over earnings of $2.28 per share from

AEON Biopharma : Corporate Deck (Final May 2026)

NYSEAMERICAN: AEON © 2 0 2 6 A E O N B IO P H A R M A Disrupting a $3.5B neurotoxin market dominated by a single brand for >30 years CORPORATE...

AEON Biopharma Reports First Quarter 2026 Financial Results and Provides Corporate Update

Reported positive FDA Type 2a meeting supporting ABP-450’s comparative analytical strategy under the 351 regulatory pathway - - Strengthened balance sheet through financing transactions and...

[10-Q] 분기 실적 — 10-Q

[8-K] 중대 사건 — 8-K

♻️ 재탕[8-K] 중대 사건 — 8-K

[ARS] ARS — ARS

[DEFA14A] DEFA14A — DEFA14A

[DEF 14A] 주주총회 위임장 — DEF 14A